+is contribution describes a simple, fast, and sensitive application of localized surface plasmon resonance e0ect of silver
nanoparticles for simultaneous determination of antihypertensive drugs’ mixture atenolol and amiloride in both pharmaceutical
dosage forms and in biological samples (urine). Silver nanoparticles were prepared by chemical reduction of silver nitrate using
hydroxylamine HCL in an alkaline medium. Application of silver-hydroxylamine nanoparticles (SH NPs) provides many advantages
including reproducibility, sensitivity, and cost e0ective way of analyte determination. Amiloride has four amino groups
which act as attachment points on the surface of silver nanoparticles resulting in a synergistic e0ect on the absorption intensity of
atenolol, leading to increase the sensitivity of the determination of both compounds. +is method shows excellent advantages
comparing with the previously reported methods, including accuracy, precision, and selectivity. +e linear range of atenolol is
1 ×10−5–1 ×10−4 mol·L−1 and of amiloride is 1 ×10−6–1 ×10−5 mol·L−1. +e limit of detection (LOD) values of atenolol and
amiloride are 0.89 ×10−5 and 0.42 ×10−6 mol·L−1, respectively.